Kronos Bio Inc (KRON) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KRON Annual Balance Sheets →
A period-by-period view of the balance sheet from Kronos Bio Inc to Mar 31 2024 helps clarify how Mar 31 2025's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent91.58
Combined Cash+Investments Total (filer-reported)93.62
Short-term Investments, Total8.16
Cash & Short-term Investments99.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.14
Total Current Assets101.87
Equipment/Property/Plant Net1.08
Other Assets, Noncurrent5.19
Operating Lease Right Of Use Asset3.05
Restricted Cash Noncurrent2.03
Total Assets108.14
Liabilities
Accounts Payable, Current AC1.57
Accrued Liabilities And Other Liabilities2.67
Other Liabilities, Current3.64
Total Current Liabilities7.88
Total Long-term Debt0.00
Other liabilities, Noncurrent20.45
Operating Lease Liability Current3.64
Operating Lease Liability Noncurrent20.45
Total Liabilities28.33
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock683.06
Retained Earnings / Accumulated Deficit-603.30
Other Equity0.00
Common Stockholder's Equity79.81
Total Stockholder's Equity79.81
Liabilities & Stockholder's Equity108.14
4 historic quarters locked

Sign in to unlock the full Kronos Bio Inc balance sheet history.

About Kronos Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001741830-25-000024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.